Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 201–300 of 1,000
Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery
Tani, H., & Tohyama, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855763 · Cited by 83
Kinnear, C., Chang, W. Y., Khattak, S., Hinek, A., Thompson, T., Rodrigues, D. C., Kennedy, K., Mahmut, N., Pasceri, P., Stanford, W. L., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0054 · Cited by 79
El‐Battrawy, I., Zhao, Z., Lan, H., Schünemann, J.-D., Sattler, K., Buljubasic, F., Patocskai, B., Li, X., Yücel, G., Lang, S., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.007 · Cited by 73
Stöhr, A., Friedrich, F. W., Flenner, F., Geertz, B., Eder, A., Schaaf, S., Hirt, M. N., Uebeler, J., Schlossarek, S., Carrier, L., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.011 · Cited by 72
Human pluripotent stem cells for disease modelling and drug screening
Maury, Y., Gauthier, M., Peschanski, M., & Martinat, C. (2011) · BioEssays · doi:10.1002/bies.201100071 · Cited by 76
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Mukherjee, U., Ong, S., Ong, S., & Hausenloy, D. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.005 · Cited by 76
Sharma, A., Wu, J. C., & Wu, S. M. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt380 · Cited by 76
One‐Step 3D Printing of Heart Patches with Built‐In Electronics for Performance Regulation
Asulin, M., Michael, I., Shapira, A., & Dvir, T. (2021) · Advanced Science · doi:10.1002/advs.202004205 · Cited by 77
Lowenthal, J., Lipnick, S., Rao, M., & Hull, S. C. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0029 · Cited by 69
SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development
Skelton, R. J. P., Costa, M., Anderson, D. J., Bruveris, F., Finnin, B. W., Koutsis, K., Arasaratnam, D., White, A. J., Rafii, A., Ng, E., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.04.016 · Cited by 83
Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.111.240374 · Cited by 76
Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies
Wu, J. C., Garg, P., Yoshida, Y., Yamanaka, S., Gepstein, L., Hulot, J., Knollmann, B. C., & Schwartz, P. J. (2019) · Circulation Research · doi:10.1161/circresaha.119.315209 · Cited by 71
Self-citationHuman Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 66
Huang, H., Pugsley, M. K., Fermini, B., Curtis, M. J., Koerner, J. E., Accardi, M. V., & Authier, S. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.04.002 · Cited by 78
Kane, C., & Terracciano, C. M. N. (2017) · Stem Cells · doi:10.1002/stem.2649 · Cited by 64
Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity
Chai, S., Wan, X., Ramirez-Navarro, A., Tesar, P. J., Kaufman, E. S., Ficker, E., George, A. L., & Deschênes, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94996 · Cited by 67
Therapy with stem cells in inflammatory bowel disease
Martínez-Montiel, P., Gómez-Gómez, G. J., & Flores, A. I. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1211 · Cited by 78
Recent advances in the applications of iPSC technology
Wiegand, C., & Banerjee, I. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.05.011 · Cited by 75
Reilly, L., & Eckhardt, L. L. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.04.008 · Cited by 69
Hayakawa, T., Kunihiro, T., Dowaki, S., Uno, H., Matsui, E., Uchida, M., Kobayashi, S., Yasuda, A., Shimizu, T., & Okano, T. (2012) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2011.0273 · Cited by 68
Cardiac Sodium Channel Nav1.5 Mutations and Cardiac Arrhythmia
Song, W., & Shou, W. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0303-y · Cited by 68
Cordeiro, J. M., Nesterenko, V. V., Sicouri, S., Goodrow, R. J., Treat, J. A., Desai, M., Wu, Y., Doss, M. X., Antzelevitch, C. N., & Diego, J. M. D. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.014 · Cited by 75
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 65
Induced pluripotent stem cell–derived cardiomyocytes in studies of inherited arrhythmias
Priori, S. G., Napolitano, C., Di Pasquale, E., & Condorelli, G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62838 · Cited by 65
Blazeski, A., Zhu, R., Hunter, D. W., Weinberg, S. H., Zambidis, E. T., & Tung, L. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.07.013 · Cited by 66
The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening
Khan, J. M., Lyon, A. R., & Harding, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02118.x · Cited by 63
Kijlstra, J. D., Hu, D., Mittal, N., Kausel, E., van der Meer, P., Garakani, A., & Domian, I. J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.017 · Cited by 65
Jung, G., Fajardo, G., Ribeiro, A. J. S., Kooiker, K. B., Coronado, M. J., Zhao, M., Hu, D., Reddy, S., Kodo, K., Sriram, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-280982 · Cited by 74
van Mil, A., Balk, G. M., Neef, K., Buikema, J. W., Asselbergs, F. W., Wu, S. M., Doevendans, P. A., & Sluijter, J. P. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy208 · Cited by 65
Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype
Macadangdang, J. R., Guan, X., Smith, A. S. T., Lucero, R., Czerniecki, S., Childers, M. K., Mack, D. L., & Kim, D. (2015) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-015-0413-8 · Cited by 65
Lin, Z. C., McGuire, A. F., Burridge, P. W., Matsa, E., Lou, H.-Y., Wu, J. C., & Cui, B. (2017) · Microsystems & Nanoengineering · doi:10.1038/micronano.2016.80 · Cited by 70
Jehuda, R. B., Eisen, B., Shemer, Y., Mekies, L. N., Szántai, Á., Reiter, I., Cui, H., Guan, K., Haron‐Khun, S., Freimark, D., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.024 · Cited by 68
Fuerstenau-Sharp, M., Zimmermann, M. E., Stark, K. J., Jentsch, N., Klingenstein, M., Drzymalski, M. A., Wagner, S., Maier, L. S., Hehr, U., Baessler, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126596 · Cited by 67
Hamasaki, M., Hashizume, Y., Yamada, Y., Katayama, T., Hohjoh, H., Fusaki, N., Nakashima, Y., Furuya, H., Haga, N., Takami, Y., et al. (2012) · Stem Cells · doi:10.1002/stem.1221 · Cited by 66
iPSC technology-Powerful hand for disease modeling and therapeutic screen
Kim, C. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.5.100 · Cited by 70
Guo, F., Sun, Y., Wang, X., Wang, H., Wang, J., Gong, T., Chen, X., Zhang, P., Su, L., Fu, G., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313518 · Cited by 63
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.06.010 · Cited by 50
Shinozawa, T., Nakamura, K., Shoji, M., Morita, M., Kimura, M., Furukawa, H., Ueda, H. R., Shiramoto, M., Matsuguma, K., Kaji, Y., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.014 · Cited by 62
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
Paci, M., Hyttinen, J., Rodríguez, B., & Severi, S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13282 · Cited by 70
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
Atienzar, F. A., Blomme, E. A., Chen, M., Hewitt, P., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter-Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 59
Zhang, H., Zou, B., Yu, H., Moretti, A., Wang, X., Yan, W., Babcock, J. J., Bellin, M., McManus, O. B., Tomaselli, G. F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205266109 · Cited by 60
Martins, A. M., Vunjak-Novakovic, G., & Reis, R. L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9487-7 · Cited by 59
Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
Oh, Y., Wei, H., Ma, D., Sun, X., & Liew, R. (2012) · Heart · doi:10.1136/heartjnl-2011-301317 · Cited by 64
Argenziano, M., Lambers, E., Hong, L., Sridhar, A., Zhang, M., Chalazan, B., Menon, A., Savio-Galimberti, E., Wu, J. C., Rehman, J., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.005 · Cited by 58
High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1
Kozek, K. A., Glazer, A., Ng, C., Blackwell, D. J., Egly, C., Vanags, L., Blair, M., Mitchell, D. W., Matreyek, K. A., Fowler, D., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.041 · Cited by 54
Kurokawa, Y. K., & George, S. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.004 · Cited by 59
Stem Cell-Derived Systems in Toxicology Assessment
Suter-Dick, L., Alves, P. M., Blaauboer, B. J., Bremm, K.-D., Brito, C., Coecke, S., Flick, B., Fowler, P., Hescheler, J., Ingelman-Sundberg, M., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0540 · Cited by 56
A modified method for isolation of human cardiomyocytes to model cardiac diseases
Guo, G., Chen, L., Rao, M., Chen, K., Song, J., & Hu, S. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1649-6 · Cited by 59
Wen, J.-Y., Wei, C., Shah, K., Wong, J., Wang, C., & Chen, H.-S. V. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0363 · Cited by 63
Modeling Timothy Syndrome with iPS Cells
Yazawa, M., & Dolmetsch, R. E. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9444-x · Cited by 61
Human induced pluripotent stem cells—from mechanisms to clinical applications
Drews, K., Józefczuk, J., Prigione, A., & Adjaye, J. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0913-0 · Cited by 71
Maizels, L., Huber, I., Arbel, G., Tijsen, A. J., Gepstein, A., Khoury, A., & Gepstein, L. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004725 · Cited by 61
Self-citationBlinova, K., Schocken, D., Patel, D., Daluwatte, C., Vicente, J., Wu, J. C., & Strauss, D. G. (2019) · Clinical and Translational Science · doi:10.1111/cts.12674 · Cited by 59
Nonxenogeneic Growth and Retinal Differentiation of Human Induced Pluripotent Stem Cells
Sridhar, A., Steward, M., & Meyer, J. S. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0101 · Cited by 61
Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling
Iglesias‐García, O., Pelacho, B., & Prósper, F. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.04.022 · Cited by 62
Ng, C., Perry, M., Liang, W., Smith, N. J., Foo, B., Shrier, A., Lukács, G. L., Hill, A. P., & Vandenberg, J. I. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.09.020 · Cited by 58
Gao, C., Shi, Q., Pan, X., Chen, J., Zhang, Y., Lang, J., Wen, S., Liu, X., Cheng, T., & Lei, K. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113892 · Cited by 66
Genomic Editing Tools to Model Human Diseases with Isogenic Pluripotent Stem Cells
Kim, H. S., Bernitz, J. M., Lee, D., & Lemischka, I. R. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0167 · Cited by 61
Mahida, S., Hogarth, A. J., Cowan, C., Tayebjee, M. H., Graham, L., & Pepper, C. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9779-5 · Cited by 60
Marchianò, S., Bertero, A., & Murry, C. E. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02165-5 · Cited by 59
hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
Li, J., Hua, Y., Miyagawa, S., Zhang, J., Li, L., Liu, L., & Sawa, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238893 · Cited by 59
Hu, N., Wang, T., Wang, Q., Zhou, J., Zou, L., Su, K., Wu, J., & Wang, P. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.07.080 · Cited by 57
Winbo, A., Ramanan, S., Eugster, E., Jovinge, S. V., Skinner, J. R., & Montgomery, J. M. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00546.2020 · Cited by 61
Rajamohan, D., Kalra, S., Hoang, M. D., George, V. T., Staniforth, A., Russell, H., Yang, X., & Denning, C. N. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0253 · Cited by 64
Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
Sala, L., Gnecchi, M., & Schwartz, P. J. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.1.1 · Cited by 54
Functional genomics and the future of iPSCs in disease modeling
Brooks, I. R., Garrone, C. M., Kerins, C., Kiar, C. S., Syntaka, S., Xu, J. Z., Spagnoli, F. M., & Watt, F. M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.03.019 · Cited by 54
Cardiomyocytes derived from human pluripotent stem cells for drug screening
Zeevi‐Levin, N., Itskovitz‐Eldor, J., & Binah, O. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.005 · Cited by 54
Laurila, E. M., Ahola, A., Hyttinen, J., & Aalto‐Setälä, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.013 · Cited by 62
Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells
Csöbönyeiová, M., Polák, Š., & Danišovič, L. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0459 · Cited by 52
Embryonic type Na+ channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome
Okata, S., Yuasa, S., Suzuki, T., Ito, S., Makita, N., Yoshida, T., Li, M., Kurokawa, J., Seki, T., Egashira, T., et al. (2016) · Scientific Reports · doi:10.1038/srep34198 · Cited by 56
Schick, R., Mekies, L. N., Shemer, Y., Eisen, B., Hallas, T., Jehuda, R. B., Ben-Ari, M., Szántai, Á., Willi, L., Shulman, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205719 · Cited by 57
3D Cell Printing of Tissue/Organ-Mimicking Constructs for Therapeutic and Drug Testing Applications
Kim, J., Kong, J. S., Han, W., Kim, B. S., & Cho, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207757 · Cited by 54
Hossain, M. K., Dayem, A. A., Han, J., Saha, S. K., Yang, G., Choi, H. Y., & Cho, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020256 · Cited by 60
Generation of Melanocytes from Induced Pluripotent Stem Cells
Yang, R., Jiang, M., Kumar, S., Xu, T., Wang, F., Xiang, L. F., & Xu, X. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.242 · Cited by 54
Modelling Human Disease with Pluripotent Stem Cells
Siller, R., Greenhough, S., Park, I., & Sullivan, G. J. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020004 · Cited by 60
Natural photoreceptors and their application to synthetic biology
Schmidt, D., & Cho, Y. K. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.10.007 · Cited by 58
Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research
Sinnecker, D., Goedel, A., Laugwitz, K., & Moretti, A. (2013) · Circulation Research · doi:10.1161/circresaha.112.268623 · Cited by 56
Pourrier, M., & Fedida, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020657 · Cited by 56
Ebert, A., Diecke, S., Chen, I. Y., & Wu, J. C. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201504395 · Cited by 55
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Tanaka, A., Yuasa, S., Node, K., & Fukuda, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818894 · Cited by 54
Burns, K. M., Byrne, B. J., Gelb, B. D., Kühn, B., Leinwand, L. A., Mital, S. R., Pearson, G. D., Rodefeld, M. D., Rossano, J. W., Stauffer, B. L., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007980 · Cited by 52
Genetics of sudden cardiac death syndromes
Chopra, N., & Knollmann, B. C. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283459893 · Cited by 56
Nozaki, Y., Honda, Y., Tsujimoto, S., Watanabe, H., Kunimatsu, T., & Funabashi, H. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.007 · Cited by 52
Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 56
Synchronized electromechanical integration recording of cardiomyocytes
Hu, N., Wang, T., Wan, H., Zhuang, L., Kettenhofen, R. F., Zhang, X., Zhang, Y. S., Xu, W., Goßmann, M., Bohlen, H., et al. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.06.017 · Cited by 51
Heritable arrhythmias associated with abnormal function of cardiac potassium channels
Crotti, L., Odening, K. E., & Sanguinetti, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa068 · Cited by 52
Personalized therapeutic strategies for patients with retinitis pigmentosa
Zheng, A., Li, Y., & Tsang, S. H. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1006192 · Cited by 60
Stem Cells - biological update and cell therapy progress
Gîrlovanu, M., Șușman, S., Şoriţău, O., Rus-Ciuca, D., Melincovici, C. S., Constantin, A.-M., & Mihu, C. M. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-483 · Cited by 45
Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells
Yang, C., Al-Aama, J. Y., Stojković, M., Keavney, B. D., Trafford, A. W., Lako, M., & Armstrong, L. (2015) · Stem Cells · doi:10.1002/stem.2070 · Cited by 53
New Opportunities: Harnessing Induced Pluripotency for Discovery in Diabetes and Metabolism
Teo, A. K. K., Wagers, A. J., & Kulkarni, R. N. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.010 · Cited by 50
Systems biology approaches to heart development and congenital heart disease
Sperling, S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr126 · Cited by 53
New and TALENted Genome Engineering Toolbox
Campbell, J. M., Hartjes, K. A., Nelson, T. J., Xu, X., & Ekker, S. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.301765 · Cited by 53
Machine learning plus optical flow: a simple and sensitive method to detect cardioactive drugs
Lee, E. K., Kurokawa, Y. K., Tu, R., George, S. C., & Khine, M. (2015) · Scientific Reports · doi:10.1038/srep11817 · Cited by 51
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy
El‐Battrawy, I., Zhao, Z., Lan, H., Li, X., Yücel, G., Lang, S., Sattler, K., Schünemann, J.-D., Zimmermann, W., Cyganek, L., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001893 · Cited by 50
Update on Brugada Syndrome 2019
Coppola, G., Corrado, E., Curnis, A., Maglia, G., Oriente, D., Mignano, A., & Brugada, P. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.100454 · Cited by 51
The evolving biology of cell reprogramming
Wilmut, I., Sullivan, G. J., & Chambers, I. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0051 · Cited by 50
Cheng, Y., Lin, F., Wang, C., Hsiao, C.-Y., Chen, H.-C., Kuo, H.-Y., Tsai, T., & Chiou, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.060 · Cited by 49
Modeling Keratoconus Using Induced Pluripotent Stem Cells
Joseph, R., Srivastava, O. P., & Pfister, R. R. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19105 · Cited by 48
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.